Join as an individual or organization
Analysing communal wastewaters for drugs and their metabolic products in order to estimate their consumption in the community is a developing field, involving scientists working in different research areas, including...
This toolkit has been produced by Adfam and family members affected by the co-occurring conditions of substance use disorders and mental ill-health. It is designed for practitioners who support those caring for a loved one who is having...
Introduction: In Mexico the consumption of tobacco and alcohol represents a public health problem. Models of screening, brief intervention and referral to treatment (SBIRT) have shown efficacy in reducing such consumption, so they are used...
This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our...
Las personas encargadas del tratamiento por abuso de sustancias, quienes ejercen la medicina clínica, los/las extensionistas, las clínicas de salud pública, entre otros, deben conocer la información que se detalla a continuación. La...
2021 INCSR–Volume I: Drug and Chemical Control (As submitted to Congress)
To read the full report, please visit: https://www.state.gov/2021-incsr-volume-i-drug-and-chemical-control-as-submitted-to-congress/
Abstract
Importance: Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine.
Objective: To compare patient satisfaction between...
Addiction neuroscience models posit that recurrent drug use increases reactivity to drug-related cues and blunts responsiveness to natural rewards, propelling a cycle of hedonic dysregulation that drives addictive behavior. Here...